Esophageal Stenosis
14
1
1
4
Key Insights
Highlights
Success Rate
57% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
21.4%
3 terminated out of 14 trials
57.1%
-29.4% vs benchmark
21%
3 trials in Phase 3/4
75%
3 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Barretts oEsophageal Resection With Steroid Therapy Trial
An Innovative Endoscopic Cap for Dilating Benign Esophageal Strictures in Children
Esophageal Replacement With a Decellularized Human Esophagus Graft
Optimal Endoscopic Suturing Pattern for Esophageal Stent Fixation
Removal of the Evolution® Esophageal Stent - Fully Covered
trūFreeze® Spray Cryotherapy Patient Registry
Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures
Intralesional Steroid Injection Versus Oral Prednisolone in Prevention of Esophageal Stricture
Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures
Corticosteroid Treatment in the Acute Phase of Caustic Ingestion Management
Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal Stenosis
Reduction in Symptomatic Esophageal Stricture Formation
PEG by Introducer Method Via EG Scan
Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation